Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pathology > WBC pathology > Flashcards

WBC pathology Flashcards

1
Q

● Disorders of white blood cells can be classified

into two broad categories:

A

● Proliferative disorders (↑ WBC Count)

● Leukopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

○ Deficiency of leukocytes

A

Leukopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Ref val

white cells

A

4.8-10.8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ref val

Granulocytes

A

40-70

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Neutrophils

A

1.4-6.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Lymphocytes

A

1.2-3.4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Monocytes

A

0.1-0.6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Eosinophils

A

0-0.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

○ Refers to an increase in the number of

white cells in the blood

A

Leukocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

● Peripheral blood leukocyte count is influenced by

several factors:

A

● 1.Size of myeloid and lymphoid precursor and
storage cell pools in the bone marrow, thymus,
circulation, peripheral tissues.
● 2.Rate of release of cells from the storage pools
into the circulation
● 3.Proportion of cells that are adherent to blood
vessel walls at any time (marginal pool)
● 4.Rate of extravasation of cells from blood to
tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

■ B-cell, T-cell and NK-cell origin
■ Lymphocyte class or stage of
maturation

A

Lymphoid neoplasms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

■ Arise from early hematopoietic progenitors

A 
Myeloid neoplasms (Segmented or 
Granular lymphocytes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

immature progenitor cells

accumulate in the BM

A

Acute myeloid leukemias (AML)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

associated with infective

hematopoiesis and resultant peripheral blood cytopenias

A

Myelodysplastic syndromes (MDS) -

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

increase production of one or more
differentiated myeloid elements
usually leads to elevated peripheral
blood counts

A

■ Myeloproliferative neoplasms -

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

➢ Chronic myeloid leukemia

(CML) falls under

A

Myeloproliferative neoplasms -

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q 
■ Macrophages and dendritic cells
■ A special type of immature dendritic 
cell, the Langerhans cell, gives rise 
to a spectrum of neoplastic disorders 
referred to as the Langerhans cell 
histiocytoses.
A

○ Histiocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

When there is mutation of the tyrosine kinase or

MYC translocation, then there is

A

a gain of function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

INHERITED GENETIC FACTORS

A

Bloom syndrome, Fanconi anemia, and ataxia telangiectasia (acute leukemia or lymphoma)

Down syndrome (trisomy 21) and type 1 
neurofibromatosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

○ Associated with nasopharyngeal
carcinoma
○ Burkitt lymphoma, Hodgkin lymphoma
(HL), B cell lymphomas

A

EBV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Kaposi sarcoma
herpesvirus)
○ Malignant effusion

A

Human herpesvirus-8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

IATROGENIC FACTORS

A

Chemotherapy - Myeloid and lymphoid

neoplasms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

SMOKING

● AML increased

A

1.3 to 2 fold in smokers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

○ Neoplasms that present widespread
involvement of the bone marrow and the
peripheral blood

A

Leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

LYMPHOID NEOPLASMS

A

Leukemia
Lymphoma
Plasma cell neoplasms
NHLs and Hodgkin lymphomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Proliferations of white cells, typically
lymphocytes, that usually present as
discrete tissue masses

A

Lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Two types of Lymphoma:

A

○ Hodgkin lymphoma

○ Non-Hodgkin lymphomas (NHL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

○ Most often arise in the bone marrow and
only infrequently involve lymph nodes or
the peripheral blood

A

● Plasma cell neoplasms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

○ Enlarged nontender lymph nodes (often
>2cm)
○ Extranodal sites (skin, stomach or brain)

A

NHLs and Hodgkin lymphomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Suppression of normal

hematopoiesis by tumor cells in the bone marrow

A

Lymphocytic leukemias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Neoplasm of Reed-Sternberg cells and variants

A

Hodgkin’s Lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Most lymphoid neoplasms resemble some

recognizable stage of

A

B- or T-cell
differentiation
○ 85-90% of lymphoid neoplasms are of B-cell origin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q 
T or F
Individuals with inherited or acquired 
immunodeficiency are at high risk of 
developing certain lymphoid neoplasms, 
particularly those caused by oncogenic 
viruses
34
Q

PRECURSOR T AND B CELL NEOPLASMS

A

ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA

35
Q

● Neoplasms composed of immature B (pre-B) or T
(pre-T) cells joined together because they show
similar tumor called lymphoblasts
● Manifest as childhood acute leukemias

A

ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA

36
Q

o About 85%
o childhood acute leukemia
o uncommonly presents as a mass in the skin
or a bone

37
Q

o Less common
o Present in adolescent males as thymic
lymphomas (thymic mass)

38
Q

is the most common cancer of children

A

ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA

39
Q

o B-ALL peaks at

40
Q

T-ALL peak in

A

adolescent

41
Q

▪ Number of normal bone marrow preB cells (cell of origin) is greatest very
early in life

42
Q

T-ALLs - mutations in

A

NOTCH1 (essential for T-cell development)

43
Q

B-ALLs - mutations in

A

PAX5, TCF3, ETV6, and
RUNX1 (genes required for proper differentiation of
early hematopoietic precursors)

44
Q

Most common numerical or structural chromosomal changes

A

hyperploidy (>50

chromosomes)

45
Q

T or F

Hyperploidy has a better prognosis than hypodiploidy
seen only in B-ALL

46
Q

Definitive diagnosis relies ________performed

with antibodies specific for B- and T-cell antigens

47
Q

Lymphoblasts are myeloperoxidase- (negative or positive)

48
Q

T or f

Lymphoblasts are myeloperoxidase-negative and
contain Periodic Acid-Schiff-positive cytoplasmic
material

49
Q

Immunostaining for terminal deoxynucleotidyl
transferase (TdT), a specialized DNA polymerase that is expressed only in pre-B and pre-T lymphoblasts is
positive in >95% of cases

A

IMMUNOPHENOTYPE

50
Q

express the pan B-cell marker CD19

and the transcription factor PAX5 as well as CD10

A

Lymphoblasts

51
Q

In very immature B-ALLs, CD10 is

52
Q

More mature “late pre-B” ALLs express

A

CD10, 19, 20,

and cytoplasmic IgM heavy chain (μ chain)

53
Q

● Characteristics of ALL are the ff:

A
  1. Abrupt stormy onset with days to few weeks of
    the first symptoms
  2. Symptoms related to depression of marrow
    function (o Fatigue due to anemia; Fever)
  3. Mass effects caused by neoplastic infiltration
    (more common in ALL) including: Bone pain, lymphadenopathy,
    splenomegaly, and hepatomegaly; testicular enlargement, Compression syndrome)
  4. Central nervous system manifestations
54
Q
  • patient
    is very red, rhetoric and
    congested
A

Compression syndrome

55
Q

Factors associated with worse prognosis:

A
  1. Age younger than 2 years
    ● strong association of infantile ALL with
    translocations involving the MLL gene
  2. Presentation in adolescence or adulthood
  3. Peripheral blood blast counts >100,000
    ● reflects a high tumor burden
56
Q

Favorable prognostic markers include:

A 
● age 2-10 years
● low WBC count
● hyperploidy
● trisomy of chromosomes 4, 7 & 10
● presence of a t(12;21)
o translocation of 12;21
57
Q

PERIPHERAL B-CELL NEOPLASMS

A

CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL
LYMPHOCYTIC LYMPHOMA

FOLLICULAR LYMPHOMA

DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

58
Q 
Chronic lymphocytic leukemia (CLL) and small 
lymphocytic lymphoma (SLL) differ only in the
A

degree of peripheral blood lymphocytosis

59
Q

Most affected patients have sufficient lymphocytosis

to fulfill the diagnostic requirement for CLL

A

absolute lymphocyte count >5000/mm3

60
Q

s the most common leukemia of adults in

the Western world

61
Q

The median age at diagnosis is __years, and there is a 2:1 male predominance

62
Q

T or F

CLL/SLL is much less common in Japan and other Asian countries than in the West

63
Q

In CLL/SLL, Most common genetic anomalies are deletions of

A

13q14.3, 11q, and 17p and trisomy 12q

64
Q

Molecular characterization of the region deleted on

chromosome 13 has implicated

A

2 microRNAs, miR-15a and miR-16-1, tumor suppressor genes

65
Q

Loss of these mIRs is believed to result in

A

overexpression of the anti-apoptotic protein BCL2, which is uniformly observed in CLL/SLL

66
Q

CLL/SLL morphology

Lymph nodes are diffusely effaced (being replaced) by

A

predominantly small lymphocytes 6 to 12 μm in
diameter with round to slightly irregular nuclei,
condensed chromatin, and scant cytoplasm

67
Q

are pathognomonic for CLL/SLL

A

Proliferation centers

Admixed are variable numbers of larger activated lymphocytes that often gather in loose aggregates referred to as proliferation centers that contain mitotically active cells

68
Q

a larger cell with a centrally placed nucleolus,

A

prolymphocyte

69
Q

CLL/SLL

A characteristic finding is the presence of

A

disrupted tumor cells (smudge cells)

70
Q

Tumor cells express the pan B-cell markers

A

CD19 and CD20, as well as CD23 and CD5

71
Q

eukopenia can be seen in individuals with

72
Q

is common and
contributes to an increased susceptibility to
infection, particularly those caused by bacteria
10% to 15% of patients develop hemolytic anemia
or thrombocytopenia due to autoantibodies made
by nonneoplastic B cells

A

Hypogammaglobulinemia

73
Q

CLL/SLL

Other variables that correlate with a worse
outcome include:

A

○ The presence of deletions of 11q and 17p
(the latter involving TP53)
○ A lack of somatic hypermutation
○ The expression of ZAP-70, a protein that augments signals produced by the Ig
receptor
○ The presence of NOTCH1 mutations

74
Q

Transformation to diffuse large B-cell

lymphoma (DLBCL) so-called

A

Richter
syndrome (approximately 5% to 10% of
patients)

75
Q

often heralded by the
development of a rapidly enlarging mass
within a lymph node or the spleen

A

Richter

syndrome

76
Q

● Most common form of indolent NHL
● It affects 15,000 to 20,000 individuals per year
● Presents in middle age and afflicts males and females
equally
● Less common in Europe and rare in Asian
populations

A

FOLLICULAR LYMPHOMA

77
Q

is strongly associated with

chromosomal translocations involving BCL2.

A

FOLLICULAR LYMPHOMA

78
Q

● Hallmark is a (14;18)
● Translocation that juxtaposes the IGH locus on
chromosome 14 and the BCL2 locus on chromosome
18.

A

FOLLICULAR LYMPHOMA

79
Q

Antagonizes apoptosis and promotes the

survival of follicular lymphoma cells

80
Q

is characteristically devoid of apoptotic cells

A

Follicular lymphoma

81
Q

encodes a histone methyltransferase,
suggesting that epigenetic abnormalities such as
changes in the patterns of histone marks have an
important role in this neoplasm.

Pathology (31 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions